Cliff Asness's AVNS Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 914,175 shares of Avanos Medical, Inc. (AVNS) worth $10.57 M, representing 0.01% of the portfolio. First purchased in 2018-Q3, this long-term strategic position has been held for 29 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in AVNS, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 367,188 shares. Largest reduction occurred in Q2 2023, reducing 29,597 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Avanos Medical (AVNS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Avanos Medical (AVNS) Trades by Cliff Asness
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2018 | +14,382 | New Buy | 14,382 | $68.49 |
| Q4 2018 | -518 | Reduce 3.60% | 13,864 | $44.79 |
| Q1 2019 | -5,738 | Reduce 41.39% | 8,126 | $42.33 |
| Q2 2019 | -8,126 | Sold Out | 8,126 | $0.00 |
| Q1 2020 | +13,810 | New Buy | 13,810 | $26.57 |
| Q2 2020 | +12,787 | Add 92.59% | 26,597 | $28.84 |
| Q3 2020 | -2,209 | Reduce 8.31% | 24,388 | $33.21 |
| Q4 2020 | -13,311 | Reduce 54.58% | 11,077 | $45.41 |
| Q1 2021 | -1,708 | Reduce 15.42% | 9,369 | $43.76 |
| Q2 2021 | +28,251 | Add 301.54% | 37,620 | $36.36 |
| Q3 2021 | +28,151 | Add 74.83% | 65,771 | $31.20 |
| Q4 2021 | -11,620 | Reduce 17.67% | 54,151 | $34.55 |
| Q1 2022 | +1,398 | Add 2.58% | 55,549 | $33.50 |
| Q2 2022 | +11,770 | Add 21.19% | 67,319 | $26.81 |
| Q3 2022 | +71,950 | Add 106.88% | 139,269 | $21.78 |
| Q4 2022 | +49,448 | Add 35.51% | 188,717 | $27.00 |
| Q1 2023 | -16,784 | Reduce 8.89% | 171,933 | $29.01 |
| Q2 2023 | -29,597 | Reduce 17.21% | 142,336 | $25.55 |
| Q3 2023 | -9,558 | Reduce 6.72% | 132,778 | $20.22 |
| Q4 2023 | -29,005 | Reduce 21.84% | 103,773 | $22.43 |
| Q1 2024 | +17,743 | Add 17.10% | 121,516 | $19.91 |
| Q2 2024 | +25,467 | Add 20.96% | 146,983 | $19.56 |
| Q3 2024 | -7,679 | Reduce 5.22% | 139,304 | $24.02 |
| Q4 2024 | -7,535 | Reduce 5.41% | 131,769 | $15.75 |
| Q1 2025 | +61,095 | Add 46.37% | 192,864 | $14.00 |
| Q2 2025 | +367,188 | Add 190.39% | 560,052 | $12.24 |
| Q3 2025 | +354,123 | Add 63.23% | 914,175 | $11.56 |
Cliff Asness's Avanos Medical Investment FAQs
Cliff Asness first purchased Avanos Medical, Inc. (AVNS) in Q3 2018, acquiring 14,382 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Avanos Medical, Inc. (AVNS) for 29 quarters since Q3 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's largest addition to Avanos Medical, Inc. (AVNS) was in Q2 2025, adding 560,052 shares worth $6.86 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 914,175 shares of Avanos Medical, Inc. (AVNS), valued at approximately $10.57 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Avanos Medical, Inc. (AVNS) represents approximately 0.01% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's peak holding in Avanos Medical, Inc. (AVNS) was 914,175 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.